18
Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics Analysis Yuan Li a† , Zhiyong Xie b, c† , Tingting Gao a , Lin Li a , Yongda Chen a , Dan Xiao b , Wen Liu b , Baorong Zou b , Biyu Lu a , Xing Tian d , Bo Han d , Yaping Guo e , Shaobao Zhang b , Lei Lin b , Mengxia Wang a , Pei Li a , Qiongfeng Liao a* a. School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. b. School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Guangzhou, 510006, China c. Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangzhou, China d. School of Pharmacy, Xinjiang Shihezi University, Xinjiang, 832002, China e. The first affiliated hospital, School of medicine, Xinjiang Shihezi university, Xinjiang, 832002, China. These authors contributed equally to this work and should be considered co-first authors. *Corresponding authors: Qiongfeng Liao Tel./Fax: +86 20 3935 8081 E-mail: [email protected] Electronic Supplementary Material (ESI) for Food & Function. This journal is © The Royal Society of Chemistry 2019

A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Supplementary Information

A Holistic View into the Gallic Acid-induced Attenuation in Colitis

Based on the Microbiome-Metabolomics Analysis

Yuan Lia†, Zhiyong Xieb, c†, Tingting Gaoa, Lin Lia, Yongda Chena, Dan Xiaob, Wen

Liub, Baorong Zoub, Biyu Lua, Xing Tiand, Bo Hand, Yaping Guoe, Shaobao Zhangb,

Lei Linb, Mengxia Wanga, Pei Lia, Qiongfeng Liaoa*

a. School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine,

Guangzhou, China.

b. School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University,

Guangzhou, 510006, China

c. Guangdong Provincial Key Laboratory of New Drug Design and Evaluation,

Guangzhou, China

d. School of Pharmacy, Xinjiang Shihezi University, Xinjiang, 832002, China

e. The first affiliated hospital, School of medicine, Xinjiang Shihezi university,

Xinjiang, 832002, China.

† These authors contributed equally to this work and should be considered co-first

authors.

*Corresponding authors:

Qiongfeng Liao

Tel./Fax: +86 20 3935 8081E-mail: [email protected]

Electronic Supplementary Material (ESI) for Food & Function.This journal is © The Royal Society of Chemistry 2019

Page 2: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Figure 1. LDA score plot

Figure 2. PCA score plot based on PICRUSt analysis

Figure 3. PCA scores plots of 1H NMR data of feces and urine

Table 1. Relative abundance of major bacterial taxa among different groups

Table 2. 1H NMR data of metabolites in rat feces

Table 3. 1H NMR data of metabolites in rat urine

Table 4. Screened metabolites with significant difference in fold change (FC)

value in feces samples

Table 5. Screened metabolites with significant difference in fold change (FC)

value in urine samples

Page 3: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Figure 1. LDA score plot

Page 4: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Figure 2. PCA score plot based on PICRUSt analysis

PICRUSt analysis shows the relative abundance of predicted microbial genes related to metabolism among groups based on Welch’s t test.

Page 5: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Figure 3. PCA scores plots of 1H NMR data of feces and urine

Table 1. Relative abundance of major bacterial taxa among different groupsPhylum Family Genus Relative abundance(%)

Page 6: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Control DSS DSS±GACorynebacteriaceae Corynebacterium 0.19±0.17 0.00±0.00## 0.04±0.05

Micrococcaceae Rothia 0.01±0.00 0.01±0.01 0.01±0.01Bifidobacteriaceae Bifidobacterium 0.03±0.06 0.02±0.05 0.03±0.06Actinobacteria

Coriobacteriaceae Adlercreutzia 0.01±0.00 0.00±.0.00## 0.01±0.01

Bacteroidaceae Bacteroides 0.77±0.36 5.54±4.57## 19.70±9.77*##

Porphyromonadaceae Parabacteroides 0.19±0.07 2.04±2.54## 1.33±1.39#

Prevotellaceae Prevotella 31.82±9.06 3.33±5.58## 0.00±0.00*##

Rikenellaceae AF12 0.05±0.04 0.00±0.00## 0.00±0.00##

S24-7 g_ 25.84±3.54 21.2±3.13 25.31±13.00Butyricimonas 0.03±0.03 0.04±0.04 0.00±0.00*##

[Odoribacteraceae]Odoribacter 0.01±0.01 0.01±0.01 0.00±0.00

[Paraprevotellaceae] Paraprevotella 4.84±5.27 5.39±5.38 3.03±1.42

Bacteroidetes

[Paraprevotellaceae] [Prevotella] 2.23±2.12 7.66±2.46## 9.68±8.20Deferribacteres Deferribacteraceae Mucispirillum 0.01±0.01 0.01±0.01 0.00±0.00

Lactobacillaceae Lactobacillus 4.40±2.02 0.61±0.49## 2.10±1.78

Streptococcaceae Lactococcus 0.00±0.00 0.02±0.02## 0.00±0.00**

Turicibacteraceae Turicibacter 0.06±0.10 0.69±0.63## 0.13±0.13*

Candidatus Arthromitus 0.00±0.00 0.00±0.00 0.01±0.01Clostridiaceae Clostridium 0.08±0.07 0.26±0.31 0.04±0.06Dehalobacteriaceae Dehalobacterium 0.04±0.02 0.02±0.02 0.10.±0.08

Blautia 0.05±0.11 0.26±.32 0.10±0.14Coprococcus 0.20±0.32 0.35±0.16 0.57±0.44

Dorea 0.04±0.02 0.20±0.19## 0.10±0.13

Firmicutes

Lachnospiraceae

Lachnospira 0.01±0.01 0.00±0.00 0.04±0.07

Page 7: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Roseburia 0.03±0.03 0.09±0.22 0.10±0.17[Ruminococcus] 0.19±0.15 0.35±0.47 0.13±0.08

Peptococcaceae rc4-4 0.02±0.02 0.13±0.03## 0.37±0.25*##

Oscillospira 2.33±1.10 5.67±4.32 5.01±2.89Ruminococcaceae Ruminococcus 4.59±1.34 2.75±0.85## 3.50±1.63

Veillonellaceae Phascolarctobacterium 0.30±0.72 1.35±0.80# 0.98±1.39

Allobaculum 0.01±0.00 0.44±0.35## 0.22±0.44##Erysipelotrichaceae

p-75-a5 0.01±0.01 0.01±0.01 0.00±0.00Alcaligenaceae Sutterella 0.42±0.17 2.70±1.49## 0.78±0.59*

Bilophila 0.02±0.02 0.00±.0.00# 0.00±0.00##Desulfovibrionaceae

Desulfovibrio 0.09±0.12 0.10±0.07 0.03±0.05*

Helicobacteraceae Flexispira 0.24±0.24 1.09±2.03 0.50±0.47

Proteobacteria

Enterobacteriaceae Proteus 0.00±0.00 0.01±0.01 0.01±0.01Spirochaetes Spirochaetaceae Treponema 4.18±5.25 0.26±0.42# 0.00±0.00##

Tenericutes Mycoplasmataceae Mycoplasma 0.02±0.02 0.04±0.03 0.06±0.05Verrucomicrobia Verrucomicrobiaceae Akkermansia 1.22±2.68 0.00±0.00# 0.00±0.00#

The data are expressed as the mean ± SD (n=6). p vales are calculated with Mann-Whitney U test. (vs. DSS :* P<0.05,**P<0.01;vs. control :# P<0.05,##P<0.01)

Page 8: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Table 2. 1H NMR data of metabolites in rat feces

Number  Metabolites δ 1H (ppm)1 2-Hydroxyisobutyrate 1.35(s)2 3-Methyl-2-oxovalerate 0.899(t), 1.093(d), 1.438(m), 1.662(m)1.685, 2.928(m), 1.924(s) 3 Alanine 1.484(d), 3.780(q)4 Acetate 1.924(s) 5 Asparagine 2.862(dd), 2.962(m), 3.993(dd)6 Aspartate 2.666(dd), 2.805(dd), 3.898(dd)7 Choline 3.191(s), 3.504(m), 4.085(m)8 Creatine 3.045(s), 3.927(s)9 Dimethylamine 2.719(s)10 Formate 8.460(s)11 Fumarate 6.525(s) 12 Glycerol 3.551(dd), 3.634(m), 3.767(m) 3.76813 Glycine 3.567(s) 14 Histidines 3.144(dd), 3.249(dd), 4.003(dd), 7.093(s), 7.844(s)15 Isoleucine 0.936(t), 0.993 (d), 1.249(m), 1.452(m), 1.971(m), 3.655(d) 16 Lactate 1.335(d), 4.125(q)17 Leucine 0.925(d), 0.935(s), 1.703(m), 3.724 (d) 18 Methylamine 2.613(s)19 Pyruvate 2.374(s)20 Succinate 2.410(s)21 Threonine 1.335(d), 3.578(d), 4.269(m)22 Xanthine 7.909(s)23 α-Glucose 3.418 (m), 3.547 (m), 3.726(m), 3.742(m), 3.772(m), 3.870 (m), 5.210(d)24 1,3-dihydroxyacetone 3.573(s), 4.42(s)

Page 9: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

25 2-Ketoisovalerate 1.127(d), 3.027(m)26 3-Methyl-2-ketovalerate 0.888(t;7.4), 1.102(d;7.0), 1.461(m), 1.727(m), 2.939(m)27 3-hydroxyphenylacetate 3.481(s), 6.757(m), 6.807(d), 6.906(dd), 7.245 (t)28 Adenine 8.196(s), 8.213(s)29 Butyrate 0.899(t), 1.553(m), 2.150(t)30 Cadaverine 1.484(d), 1.727(m), 3.022(t)31 DCA 6.859(d)32 desaminotyrosine 3.817(d)33 Ethanolamine 3.134(d), 7.850(d;7.6)34 Glutarate 1.775(overlap), 2.181(t)35 Hypoxanthine 8.196(s), 8.216(s)36 Imidazole 7.327(s), 8.297(s)37 Isocaproate 0.882(d), 1.449(m), 1.484 (d), 2.189 (t)38 Malonate 3.112(s)39 Methanol 3.366(s)40 Methionine 2.142 (s), 2.169(m), 2.648(t), 3.853(m)41 Methylsuccinate 1.104(d), 2.135 (d), 2.635 (m)42 N-acetyl-glycoprotein 2.03(s)43 NAG 2.042(s), 2.065(s)44 Phenylacetate 3.542(s), 7.317(m), 7.375(m)45 Propionate 1.060(t), 2.187(q), 2.374(s)46 Sarcosine 2.705(s), 3.598(s)47 Taurochenodeoxycholate 0.957, 0.672(s), 0.965(s)48 TCA 0.67(s)49 Trimethylamine 2.871(s)50 Tyrosine 3.068(d), 3.140(dd), 3.941(d), 6.907(m), 7.196 (d/m51 Uracil 5.807(d), 7.542(d) 52 Urocanate 6.40(d), 7.318(d), 7.433(s), 7.885(s)53 Valerate 0.899(t), 1.309(m), 2.178(t)

Page 10: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

54 Valine 0.972(d), 1.013(d), 2.275(m), 3.617(d), 7.909(s)55 α-arabinose 3.849(dd), 3.906(m), 3.993(t), 4.023(d), 5.242 (d)56 α-galactose 3.64(dd), 4.08(m), 4.58(d), 5.274 (d)57 α-ketoisocaproate 0.920 (s), 2.054(m), 2.616(d)58 α-ketoisovalerate 1.127(d), 3.022(m)59 α-xylose 3.545(dd), 3.630(m), 3.670 (t), 5.203(d)60 β-arabinose 3.525(dd), 3.670 (t), 3.856(dd), 3.945(m), 4.523(d)61 β-L-Fucose 1.251(d:6.5), 3.452(m), 3.645 (m), 3.804 (m) , 4.561 (d;7.9)62 β-xylose 3.23(dd), 3.46(t), 3.63(m), 3.932(dd), 4.570(d)

Abbreviation: TCA, Taurocholic acid; DCA, Deoxycholic acid; NAG, N-Acetyl group contained glycoprotein

Page 11: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Table 3. 1H NMR data of metabolites in rat urine

1H NMR Data of Metabolites in Rat Urine

Number Metabolites δ 1H (ppm)1 1-Methylnicotinamide 4.476(s),8.181(t),8.894(d),8.960(d),9.272(s)2 2-Hydroxy-3-methylvalerate 0.8(t),0.93(d),1.15(m),1.35(m),1.75(m),3.87(d)3 2PY 6.67(d), 7.97(dd), 8.34(d), 3.65(s)4 3-Hydeoxyphenylacetate 3.490(s),6.794(m),6.872(m or ov),7.258(tr or ov)5 3-Hydroxyisovalerate 1.275(s), 2.357(s)6 4-Hydroxyhippurate 3.978(s),6.976(d),7.765(d)7 4-hydroxyphenylacetate 6.87(d)8 4PY 6.70(d),7.83(dd) ,8.56(d) ,3.90(s)9 4-Pyridoxate 2.429(s),7.834(s)10 Acetamide 1.99(s) 11 Acetoacetate 2.266(s),3.434(s)12 Acetone 2.229(s)13 Acetylcarnitine 2.159(s), 2.504(m), 2.631(m), 3.202(s), 3.621(d), 3.829(dd), 14 Allantoin 5.38(s), 6.02(s), 7.27(s), 8.01(s)15 Betaine 3.273(s),3.927(s)16 Carnitine 2.41(t),3.230(s),3.405(m),4.554(m)17 cis-aconitate 3.123(s/d),5.711(t)18 Creatinine 3.043(s),4.052(s)19 Dimethyl sulfone 3.145(s)20 Galactarate 3.95(s), 4.26(s)21 Galactonate 4.26(s)22 Glycerate 3-phosphate 4.22(m), 4.06(d), 3.84(d)

Page 12: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

23 Glycolate 3.932(s)24 Guanidoacetate 3.801(s)25 Guanine 7.69(s)26 Hippurate 3.975(d), 7.553(t), 7.642(t), 7.837(d), 8.508(s)27 Hypotaurine 3.36(t)28 Indole-3-acetate 3.681 (s), 7.161 (t), 7.216 (t), 7.507 (d), 7.635(d)29 Isobutyrate 1.053 (d), 2.382(m)30 Isopropanol 1.146 (d), 4.028(m)31 Isovalerate 0.895(d), 1.929(m), 2.049(d)32 Isovalerylglycine 0.925(d), 1.994(m), 2.166(d),3.746(d)33 Ketoleucine 0.944 (d), 2.100 (m), 2.617(d)

34 Lactose 3.276 (t), 3.507 (m), 3.604 (m), 3.710 (m), 3.768 (m), 3.847 (m), 3.936 (m), 4.455 (d), 4.660 (d), 5.211(d)

35 Methylguanidine 2.828 (s), 3.356(s)36 N, N-dimethylglycine 2.925 (s), 3.712(s)37 N6, N6, N6-trimethyllysine 3.109(s)38 N-acetylglutamate 4.13(t), 1.83(m), 2.27(t), 2.04(s)39 N-Acetylglycine 2.044 (s), 3.763 (d), 7.997(s)40 N-methylhydantoin 2.91(s), 4.08(s)41 N-Nitrosodimethylamine 3.162 (s), 3.802(s)42 N-Phenylacetylglycine 3.67(s), 3.74(d), 7.98(s)43 O-Acetylcholine 2.143 (s), 3.202 (s), 3.711 (t/m), 4.529(m)44 Oxypurinol 8.209(s)45 Pantothenate 0.94(s), 0.90(s), 3.52(s), 3.40(s), 4.00(s), 3.45(t), 2.43(t) 46 p-cresol 2.253 (s), 6.817 (d), 7.130(d)47 p-Cresol glucuronide 2.299 (s), 7.055 (m), 7.237(m)48 p-cresol sulfate 2.347(s), 7.217 (d), 7.293(s,d,d)49 Phenylacetylglycine 3.680 (s), 3.746 (d), 7.365 (t), 7.425(t)

Page 13: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

50 Phosphorylcholine 3.203 (s), 3.671 (t), 4.190(dd)51 Propylene glycol 1.14(d), 3.44(dd), 3.54(dd), 3.88(m)52 Succinimide 2.78(s)53 Thiamine 9.42(s), 8.04(s), 5.45(s), 3.89(t), 3.18(t), 2.56(s), 2.49(s)54 Trans-Aconitate 3.435 (s), 6.571(s)55 Trigonelline 4.438 (s), 8.084 (t), 8.837 (t/d), 9.122(s)56 TMAO 3.266(s)57 β-Glucose 3.243 (t), 3.478 (m), 3.492 (m), 3.864 (m), 3.927 (s), 4.660(d)58 4-hydroxyphenylacetate 3.45(s), 6.87(d), 7.16(d)59 3-hydroxyisobutyrate 1.06(d), 2.48(m), 3.52(m), 3.71(m)60 GPC 3.24(s), 3.69(m), 4.33(m)61 NAG 2.04(s) 62 PC 3.22(s), 3.60(m), 4.17(m)63 Dimethylglycine 2.92(s), 3.72(s)64 2-Hydroxyisobutyrate 1.35(s)65 3-Methyl-2-oxovalerate 0.899(t), 1.093(d), 1.438(m), 1.662(m), 2.928(m)66 Alanine 1.489(d), 3.780(q) 67 Acetate 1.927(s)68 Asparagine 2.862(dd), 2.962(m), 3.995(dd)69 Choline 3.191(s), 3.504(t/m), 4.085(m)70 Citrulline 1.558(m), 1.865(m), 3.124(dd), 3.743(t)71 Creatine 3.028/3.047(s), 3.926(s)72 DMA 2.719(s)73 Formate 8.467(s)74 Fumarate 6.524(s)75 Glycine 3.566(s)76 Isoleucine 0.936(t), 0.995(d), 1.249(m), 1.452(m), 1.971(m), 3.655(d)77 Lactate 1.331(d), 4.115(q)

Page 14: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

78 Leucine 0.925(d), 0.936(s/d), 1.703(m), 3.725(d)79 Pyruvate 2.373(s)80 p-Hydroxyphenylacetate 3.445(s), 6.865 (d), 7.169(d)81 Succinate 2.413(s)82 Taurine 3.243(t), 3.435(t)83 Threonine 1.330(d), 3.579(d), 4.269(m)84 Xanthine 7.909(s)

Abbreviation: 2PY, N'-methyl-2-pyridone-5-carboxamide; 4PY, N'-methyl-4-pyridone-3-carboxamide; TMAO, Trimethylamine-N-oxide; GPC, Glycerophosphocholine; NAG, N-Acetyl group contained glycoprotein; PC, Phosphorylcholine; DMA, Dimethylamine;

Page 15: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Table 4. Screened metabolites with significant difference in fold change (FC) value in feces samples.

DSS / Control   DSS+GA / Control   DSS+GA / DSSNumber Metabolites

FC p value Trend   FC p value Trend   FC p value Trend1 Valerate 2.618 0.007 ↑** 0.450 0.012 ↓*2 Butyrate 1.987 0.014 ↑* 0.532 0.013 ↓*3 Glutarate 1.740 0.01 ↑* 0.578 0.012 ↓*4 Taurochenodeoxycholate 1.655 0.009 ↑**5 Glycine 1.563 0.005 ↑** 1.544 0.002 ↑**6 Methionine 1.517 0.006 ↑** 0.712 0.013 ↓*7 3-Methyl-2-ketovalerate 1.515 0.015 ↑* 0.640 0.013 ↓*8 Propionate 1.509 0.014 ↑* 0.635 0.007 ↓**9 Methylsuccinate 1.503 0.014 ↑* 0.699 0.024 ↓*10 3-Methyl-2-oxovalerate 1.465 0.029 ↑* 0.627 0.013 ↓*11 Acetate 1.465 0.027 ↑* 0.688 0.030 ↓*12 Dimethylamine 0.809 0.002 ↓**13 Adenine 0.800 0.046 ↓*14 Uracil 0.776 0.025 ↓*15 Fumarate 0.739 <0.001 ↓*** 0.733 0.003 ↓**16 Deoxycholic acid 0.637 <0.001 ↓*** 0.703 0.002 ↓**17 Asparagine 1.264 <0.001 ↑***18 Desaminotyrosine 1.261 0.005 ↑** 1.212 0.032 ↓*19 Alpha-arabinose 1.208 0.005 ↑**20 Xanthine 0.750 <0.001 ↓***21 α-galactose 1.234 <0.001 ↑***22 β-xylose 1.280 0.003 ↑**23 β-arabinose 1.249 0.004 ↑**24 α-xylose 1.240 0.008 ↑**

Page 16: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

25 Isocaproate                 0.782 0.018 ↓**p<0.05; **p<0.01, ***p<0.001

Page 17: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

Table 5. Screened metabolites with significant difference in fold change (FC) value in urine samplesDSS / Control   DSS+GA / Control   DSS+GA / DSS

Number MetabolitesFC p value Trend   FC p value Trend   FC p value Trend

1 Oxypurinol 0.337 <0.001 ↓*** 2.771 <0.001 ↑***2 Xanthine 0.588 <0.001 ↓*** 1.691 <0.001 ↑***3 4-Hydroxyhippurate 0.714 <0.001 ↓*** 0.648 <0.001 ↓***4 Hippurate 0.719 <0.001 ↓*** 0.650 <0.001 ↓***5 cis-aconitate 0.792 <0.001 ↓***6 Galactarate 0.815 <0.001 ↓***7 Isovalerate 1.421 <0.001 ↑*** 1.280 <0.001 ↑***8 Acetoacetate 0.723 0.045 ↓*9 Succinate 1.605 0.021 ↑*10 Fumarate 0.806 0.020 ↓*11 Isopropanol 0.707 0.016 ↓* 0.742 0.033 ↓**12 Acetate 2.154 0.011 ↑* 1.316 0.002 ↑**13 Taurine 0.646 0.008 ↓**14 trans-Aconitate 0.506 0.008 ↓**15 Trigonelline 0.830 0.006 ↓** 1.219 0.002 ↑**16 4-Pyridoxate 0.741 0.005 ↓** 0.628 <0.001 ↓***17 2-Hydroxyisobutyrate 1.542 0.003 ↑** 1.338 <0.001 ↑***18 Formate 1.659 0.001 ↑** 0.661 0.010 ↓**19 Indole-3-acetate 0.674 <0.001 ↓***20 succinimide 1.239 <0.001 ↑***21 p-Cresol glucuronide 0.753 <0.001 ↓***22 Glycolate 0.783 <0.001 ↓***23 Asparagine 0.800 <0.001 ↓***24 Phenylacetylglycine         0.797 <0.001 ↓***        

Page 18: A Holistic View into the Gallic Acid-induced Attenuation ... · Supplementary Information A Holistic View into the Gallic Acid-induced Attenuation in Colitis Based on the Microbiome-Metabolomics

*p<0.05; **p<0.01, ***p<0.001